Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-03-15
2011-03-15
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S156000
Reexamination Certificate
active
07906650
ABSTRACT:
This invention provides novel compounds, and pharmaceutically acceptable derivatives thereof, that are useful as caspase inhibitors. These compounds have the general formula I:where R1, R2, and R3are as described herein, Ring A contains zero to two double bonds, each X is independently selected from nitrogen or carbon, at least one X in Ring A is a nitrogen, Ring A is optionally substituted as described, and may be fused to a saturated or unsaturated five to seven membered ring containing zero to three heteroatoms, and provided that when X3is a carbon, a substituent on X3is attached by an atom other than nitrogen.
REFERENCES:
patent: 5801148 (1998-09-01), Gyorkos et al.
patent: 7517987 (2009-04-01), Golec et al.
patent: 9816502 (1998-04-01), None
Binch Hayley Marie
Charifson Paul S.
Charrier Jean-Damien
Golec Julian M. C.
Che Jennifer G.
Dixon Lisa A.
Seaman D. Margaret
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
LandOfFree
Caspase inhibitors and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Caspase inhibitors and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Caspase inhibitors and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2679157